Health Care·Life Sciences Tools & Services·$32.7B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.37 | N/A | +4.98% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $1.37 | N/A | +4.98% |
| Revenue | N/A | N/A | N/A |
Tone: Cautiously Optimistic
Overall, management conveyed a cautious optimism regarding the company's performance. They acknowledged current market conditions while emphasizing their strategic focus.
Management expressed satisfaction with the EPS performance despite not providing revenue figures.
They highlighted ongoing market challenges but remain focused on long-term growth.
Agilent Technologies reported a better-than-expected EPS, which indicates strong profitability. However, the stock saw a slight decline of 0.15%, suggesting that investors may have been looking for more comprehensive revenue details or guidance. The lack of revenue data and future guidance could be contributing factors to the muted stock reaction.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
ONEOK INC NEW
Feb 27, 2023